Cosmoderm India Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 20.00 K
- Company Age 4 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 5.00 M
- Revenue Growth 4.66%
- Profit Growth 17.23%
- Ebitda 18.24%
- Net Worth 90.01%
- Total Assets 49.24%
About Cosmoderm India
Cosmoderm India Private Limited (CIPL) is a Private Limited Indian Non-Government Company incorporated in India on 11 April 2020 (Four years and ten months 12 days old ). Its registered office is in Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 20.00 K .
The company currently has active open charges totaling ₹5.00 M.
Raj Batra and Shivani Batra serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24290DL2020PTC363229
- Company No.
363229
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Apr 2020
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Cosmoderm India?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Raj Batra  | Director | 11-Apr-2020 | Current |
| Shivani Batra | Director | 11-Apr-2020 | Current |
Financial Performance of Cosmoderm India.
Cosmoderm India Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 4.66% increase. The company also saw a substantial improvement in profitability, with a 17.23% increase in profit. The company's net worth Soared by an impressive increase of 90.01%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Cosmoderm India?
Unlock access to Cosmoderm India's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Cosmetologie Private LimitedShivani Batra is a mutual person
Charges (Loans)
₹5.00 M
₹0
Charges Breakdown by Lending Institutions
- Axis Bank Limited : 0.50 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Feb 2023 | Axis Bank Limited | ₹5.00 M | Open |
How Many Employees Work at Cosmoderm India?
Cosmoderm India has a workforce of 0 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cosmoderm India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cosmoderm India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.